Ibalizumab long-term efficacy is not impacted by partially active antiretrovirals

Leider, J; McLaughlin, T; Lee, A; McGary, C; Mesquita, P

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022; 25 (): 123